Hikma Pharmaceuticals Plc Director/PDMR Shareholding (1152J)
11 August 2023 - 3:00PM
UK Regulatory
TIDMHIK
RNS Number : 1152J
Hikma Pharmaceuticals Plc
11 August 2023
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Hikma Pharmaceuticals PLC - Executive Incentive Plan Option
Exercise and Sale
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Acquisition of Shares pursuant to the exercise
transaction of options granted at nil-cost under the 2014
Executive Incentive Plan
c) Price(s) and Price(s): nil
volume(s) Volume(s): 25,012
d) Aggregated information
* Volume
25,012
nil
* Price nil
* Total
e) Date of the transaction 10 August 2023
f) Place of the Outside a trading venue
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Sale of Shares
transaction
c) Price(s) and Price(s): GBP22.03
volume(s)
Volume(s): 25,012
d) Aggregated information
- Volume
25,012
GBP22.03
- Price GBP551,208.96
- Total
e) Date of the transaction 10 August 2023
f) Place of the London Stock Exchange (XLON)
transaction
Helen Middlemist, Deputy Company Secretary
+44 (0) 20 7399 2760
11 August 2023
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBBGDIXSBDGXB
(END) Dow Jones Newswires
August 11, 2023 09:00 ET (13:00 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
Von Mai 2023 bis Mai 2024